China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 
Australia's Social Media Ban for Under-16s Sparks Global Movement 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
China's Push to Steal Taiwan's Chip Technology and Talent Raises Security Alarms 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
